APA (7th ed.) Citation

Pampalakis, G., Angelis, G., Zingkou, E., Vekrellis, K., & Sotiropoulou, G. (2022). A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis. Clinical & Translational Medicine, 12(1), 1. https://doi.org/10.1002/ctm2.657

Chicago Style (17th ed.) Citation

Pampalakis, Georgios, Georgios Angelis, Eleni Zingkou, Kostas Vekrellis, and Georgia Sotiropoulou. "A Chemogenomic Approach Is Required for Effective Treatment of Amyotrophic Lateral Sclerosis." Clinical & Translational Medicine 12, no. 1 (2022): 1. https://doi.org/10.1002/ctm2.657.

MLA (9th ed.) Citation

Pampalakis, Georgios, et al. "A Chemogenomic Approach Is Required for Effective Treatment of Amyotrophic Lateral Sclerosis." Clinical & Translational Medicine, vol. 12, no. 1, 2022, p. 1, https://doi.org/10.1002/ctm2.657.